Study: Drug therapy for Alzheimer's patients deemed cost effective

Share this article:

Treating patients with moderately severe to severe Alzheimer's disease with the drug memantine is more cost-effective than no therapy, according to a European study in the journal Clinical Drug Investigation. Lundbeck SA, Paris, which markets the memantine as Ebixa, provided funding for the study.

Dr. Clement Francois, from Lundbeck SA, and colleagues estimated the cost implications of using memantine relative to no drug therapy over a five-year-period in patients with moderate to severe Alzheimer's disease in Finland.

"Memantine therapy was associated with approximately four extra months of independence, one additional month of residence in the community, and a cost reduction relative to placebo of approximately 1,700 euros [$2,000] per patient over 5 years," the authors write. The figures were based on 2001 costs.

Forest Laboratories sells memantine under the trade name Namenda in the United States. Merz Pharma GmbH of Germany markets it as Axura.

Share this article:

More in News

Double homicide at Houston nursing home; victims' roommate arrested

Double homicide at Houston nursing home; victims' roommate ...

A double murder occurred late Tuesday night in a Houston nursing home room shared by four men, according to local authorities. Police arrested Guillermo Correa on suspicion of beating two ...

$2 million HIPAA settlement highlights mobile device risks facing healthcare providers

Laptops and other mobile devices containing personal health information have been stolen from long-term care ombudsman programs and other healthcare organizations, including from Concentra Health Services and QCA Health Plan Inc. Now, Concentra and QCA have agreed to legal settlements totaling nearly $2 million, federal ...

Long-term care nurses often 'scramble' to get family members' blessing for palliative ...

Nursing home residents might not transition to full palliative care until they are very near death, at which point nurses and family members act in a state of crisis, suggests recently published research out of Canada.